新加坡 - 英文 - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - general hospital - the administration set is to be used for injection (administration) of novo nordisk factor products and contains: 1 sterile infusion set (tubing and butterfly with needle protection), 2 sterile alcohol swabs, 2 sterile gauze pads and 2 sterile plasters

新加坡 - 英文 - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - general hospital - intended to deliver novo nordisk insulin products packaged in a 3 ml penfill® cartridge and used together with novofine® needles.

以色列 - 英文 - Ministry of Health

novo nordisk ltd., israel - insulin degludec - solution for injection - insulin degludec 200 u/ml - insulin degludec - treatment of diabetes mellitus in adults, adolescents and children from the age of 1 year.

以色列 - 英文 - Ministry of Health

novo nordisk ltd., israel - turoctocog alfa pegol - powder and solvent for solution for injection - turoctocog alfa pegol 1000 iu/vial - treatment and prophylaxis of bleeding in previously treated patients with haemophilia a (congenital factor viii disorder).esperoct® does not contain pharmacologically active quantities of von willebrand factor and is, therefore, unsuitable for the treatment of von willebrand disease.

以色列 - 英文 - Ministry of Health

novo nordisk ltd., israel - nonacog beta pegol - powder and solvent for solution for injection - nonacog beta pegol 1000 iu/vial - coagulation factor ix - treatment and prophylaxis of bleeding in pretreated patients with haemophilia b (congenital factor ix deficiency).

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - insulin aspart 100 iu/ml;   - suspension for injection - 100 iu/ml - active: insulin aspart 100 iu/ml   excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium chloride sodium hydroxide water for injection zinc as chloride - the treatment of diabetes mellitus

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - insulin aspart 100 u/ml;   - solution for injection - 100 u/ml - active: insulin aspart 100 u/ml   excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc as the chloride - the treatment of diabetes mellitus.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - insulin aspart 100 iu/ml;   - solution for injection - 100 iu/ml - active: insulin aspart 100 iu/ml   excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc as chloride - the treatment of diabetes mellitus

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - insulin aspart 100 u/ml;   - solution for injection - 100 u/ml - active: insulin aspart 100 u/ml   excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc as the choloride - the treatment of diabetes mellitus.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - eptacog alfa (activated) 1mg - powder for injection with diluent - 1 mg - active: eptacog alfa (activated) 1mg excipient: calcium chloride dihydrate glycylglycine mannitol methionine nitrogen polysorbate 80 sodium chloride sucrose histidine water for injection - indicated for the control of bleeding and surgical prophylaxis in patients: · with inhibitors to coagulation factors viii or ix · with congenital fvii deficiency · with glanzmann's thrombasthenia, who have antibodies to gpiib-iiia and/or hla, and with past or present refractoriness to platelet transfusions